We have carried out a prospective double-blind randomized study in 40 patients with infusion-related thrombophlebitis. Twenty-two patients were included in the glyceryltrinitrate (GTN) ointment group and 18 patients in the control heparinoid group. Pain was assessed by an analogue scale. At 48 hours the analgesic index was 84.6 ± 18 units with GTN and 49 ± 45 units with heparinoid ointment (P <0.01). Faster relief of oedema was also observed in the GTN-treated group. All signs of thrombophlebitis were relieved in less than 4 days in the GTN group compared with 9 days in the controls (P < 0.005). We conclude that transdermal GTN is useful therapy for infusion-related thrombophlebitis showing evidence of anti-inflammatory and analgesic effect.
Introduction
Infusion-related thrombophlebitis ('thrombophlebitis') occurs in between 30 and 70% of intravenous infusions in hospital.`3 The origin could be injury ofthe endothelium produced by the catheter, chemical damage induced by pharmacological substances or infection through the catheter. 4 Treatment has included local heat, elevation of the extremity, anti-inflammatory nonsteroidal drugs and sometimes transdermal heparinoid substances, although these measures have only doubtful beneficial effects. 58 Recently good results have been obtained in preventing thrombophlebitis using transdermal glyceryltrinitrate (GTN),9"0 but until now its effects as a treatment of thrombophlebitis were unknown.
The vascular endothelium produces nitric oxide, a vasodilator substance," which also regulates the interaction ofplatelets with each other and with the vascular endothelium.'2,3 Nitric oxide (NO) also has other actions not related to the cardiovascular system.'4 Many vasodilator substances act by inducing the liberation of this potent mediator by the vascular endothelium. Nitrovasodilators, including GTN, act independently of the endothelium, by releasing NO.'5 Both endothelium-derived and GTN-derived NO act via a second messenger, guanosine-3', 5'-cyclic monophosphate (cGMP). '5 To test whether GTN has anti-inflammatory and analgesic effects, we conducted a prospective double-blind randomized and controlled clinical study in patients with infusion-related thrombophlebitis, comparing transdermal GTN treatment against a control group that was treated with an ointment of heparinoid substance (sulphuric polyholoside ester sodium salt, SPE). We also measured changes in the urinary levels of cGMP induced by the treatment.
Patients and methods
The study was carried out using patients from different units of the hospital, all of whom had developed a thrombophlebitis of a superficial forearm vein during a therapeutic venous infusion. Thrombophlebitis was defined as the presence of two or more of the following signs: pain, local warmth, erythema, local oedema and/or palpable venous cord. The patients had not received any previous treatment for thrombophlebitis. After patient acceptance they were included in the previously randomized group. It was accepted by the ethical committee and we obtained an informed consent of all patients.
The exclusion criteria applied were: local infection, hypovolaemia and arterial hypotension, Follow-up for complete disappearance of signs of the thrombophlebitis in each group is shown in Figure 1 . In the GTN group 18 patients show disappearance of all signs of thrombophlebitis in 1-2 days (82%) while only six patients (33%) (P <0.05) were healed in the SPE group at the time. All patients in the GTN group were free of signs of thrombophlebitis within 4 days. In the SPE group 10 patients (56%) required between 4 and 9 days for complete disappearance of signs of thrombophlebitis (P < 0.005).
The reduction in pain was significantly higher in the GTN group than in the SPE group. The analgesic index was 84.6 ± 18 (excellent) at 48 hours in the GTN group, compared with 49 ± 45% (reasonable) in the SPE group (P <0.01).
The basal level of urinary cGMP in the SPE group was 1,447.6 ± 1,134.3 pmol/mg Cr and Grade III 5 5 Grave IV 7 6 Grade V There were no significant differences. Two patients in the GTN group experienced headache as a side effect.
Discussion
Infusion-related thrombophlebitis is a common disturbance that exhibits different degrees of inflammatory symptoms.'-4 Reports of the prevention of thrombophlebitis with GTN patches have been published,9'0 but it has not been shown until now that GTN could reverse the inflammatory signs of thrombophlebitis.
The development of infusion-related thrombophlebitis is independent of whether its cause is mechanical or chemical. Sometimes it is cured spontaneously in a few days, but generally it is treated with a number ofdifferent approaches, such as local heat, non-steroidal anti-inflammatory substances and semi-synthetic transdermal heparinoid substances. 4 8 In this study we demonstrate that treatment of thrombophlebitis with transdermal GTN was more effective than the heparinoid SPE, which is commonly used in this condition.7'8 The time to resolution of phlebitis with SPE was similar to that which would be achieved without the use of pharmacologically active agents. 8 The superficial vein when inflammed is easily reached by the transdermal action of GTN. The absorption of transdermal GTN is dependent on the areas of application, the blood flow in the skin and the degree of evaporation.'8 Cardiovascular effects can be observed between 15 and 60 minutes after application of 2% gel at doses of 12.5-50 mg; the maximum effect is obtained between 30 and 60 minutes, and blood levels of 3 -9 
